Pub Date : 1900-01-01DOI: 10.2991/AHSR.K.210127.039
Yurmianti Rante Allo, Susana Ramandey, S. Wahyuni
—Adherence to antiretroviral therapy (ARV) is the key to suppressing the development of HIV disease, reducing the risk of drug resistance, improving overall health, improving quality and survival and reducing the risk of HIV transmission. A mother must comply with ARV therapy to prevent transmission from mother to child. Loss to follow up with antiretroviral (ARV) drugs in mothers can increase the risk of HIV transmission from mother to child. This study aims to ascertain the determinants of loss to follow up of HIV pregnant women taking ARV therapy in Preventing Mother-to-Child Transmission (PMTCT) at the Jayapura Regional General Hospital. This research uses a qualitative method with a case study approach. Data collection was carried out through in-depth interviews, observation, focus group discussions (FGD), field notes and documentation with 7 HIV pregnant women who were recorded as not compliant to undergo ARV therapy. Data analysis was performed descriptively using triangulation and content analysis methods. The results of this study reveal that the determinants of loss to follow up with ARV therapy are low vulnerability and perception of illness, the presence of stigma and discrimination that is still high and low social support. With the results of the above study, one conclusion is drawn that the determinants loss to follow up of pregnant women with ARV therapy will add many new cases of HIV in Papua. So that if it is not handled better, then the Three Zero target in 2030 will only discourse
{"title":"Determinants of Loss to Follow Up (LTFU) With HIV Pregnant Women on Antiretroviral Therapy in Programs Prevention for Mother to Child Transmission (PMTCT) in Jayapura Regional Public Hostipal: A Qualitative Study","authors":"Yurmianti Rante Allo, Susana Ramandey, S. Wahyuni","doi":"10.2991/AHSR.K.210127.039","DOIUrl":"https://doi.org/10.2991/AHSR.K.210127.039","url":null,"abstract":"—Adherence to antiretroviral therapy (ARV) is the key to suppressing the development of HIV disease, reducing the risk of drug resistance, improving overall health, improving quality and survival and reducing the risk of HIV transmission. A mother must comply with ARV therapy to prevent transmission from mother to child. Loss to follow up with antiretroviral (ARV) drugs in mothers can increase the risk of HIV transmission from mother to child. This study aims to ascertain the determinants of loss to follow up of HIV pregnant women taking ARV therapy in Preventing Mother-to-Child Transmission (PMTCT) at the Jayapura Regional General Hospital. This research uses a qualitative method with a case study approach. Data collection was carried out through in-depth interviews, observation, focus group discussions (FGD), field notes and documentation with 7 HIV pregnant women who were recorded as not compliant to undergo ARV therapy. Data analysis was performed descriptively using triangulation and content analysis methods. The results of this study reveal that the determinants of loss to follow up with ARV therapy are low vulnerability and perception of illness, the presence of stigma and discrimination that is still high and low social support. With the results of the above study, one conclusion is drawn that the determinants loss to follow up of pregnant women with ARV therapy will add many new cases of HIV in Papua. So that if it is not handled better, then the Three Zero target in 2030 will only discourse","PeriodicalId":424952,"journal":{"name":"Proceedings of the International Conference on Health and Medical Sciences (AHMS 2020)","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133984303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.2991/AHSR.K.210127.016
T. Hidayat, Sugiarto, B. Wiboworini
— Most people with diabetes mellitus (DM) type 2 have increased lipid prevalence. An increase in cholesterol levels can reach 28% to 34%. High cholesterol levels accompanied by an increase in blood pressure in people with type-2 DM can increase the risk of cardiovascular disease. Proper nutritional support in the patient with type-2 DM is needed in controlling blood sugar along with controlling cholesterol levels and blood pressure. FortemDia_Tri is the development of a liquid dietary modification as nutritional support based on tempeh flour and mung beans as the main source of isoflavones and other ingredients such as skim milk flour, brown rice flour, canola oil, and maltodextrin, which are recommended for type-2 DM patients. Most commercial formulas do not contain isoflavones. The purpose of this research is to determine the effect of nutritional support for commercial formulas and FortemDia_Tri on reducing cholesterol levels and blood pressure in patients with type-2 DM. The sample of this study includes 33 patients with type-2 DM with the sample who neither takes insulin therapy nor consumes cholesterol-lowering drugs. Some samples were divided into 3 groups: control group (P1) given DM dietary education (n=11), P2 group given commercial formula (n = 11), and P3 group given the FortemDia_Tri (n=11). The dosage of commercial formula and FortemDia_Tri was 500 ml and 400 ml/day/person given 2 times/day, respectively. The intervention was done in 5 days. This study is analytical research with a randomized experimental study approach. The research design used is the pretest-posttest control-group design. The data of this research were analyzed with a one-way ANOVA test with the posthoc LSD test. After 5 days of treatment, there was a change in the level of total cholesterol of P2 group (-8.91 ± 23.17 mg/dl) with p = 0.231, and P3 group (-40.09 ± 25.04 mg/dl) with p = 0.000). Meanwhile, there was no change in the control group, and there was a significant difference between those groups (p = 0.001). P3 group has reduced more blood pressure than P1 and P2 groups, but the decrease was not different between the groups (p > 0.05). The FortemDia_Tri nutritional support can help reduce cholesterol levels and blood pressure in patients with type-2 DM. Further studies with longer duration and more sample sizes areneeded.
{"title":"The Effect of Nutrition Support of Commercial Formula and FortemDia_Tri on Total Cholesterol Level and Blood Pressure in Type 2 Diabetes Mellitus Patients","authors":"T. Hidayat, Sugiarto, B. Wiboworini","doi":"10.2991/AHSR.K.210127.016","DOIUrl":"https://doi.org/10.2991/AHSR.K.210127.016","url":null,"abstract":"— Most people with diabetes mellitus (DM) type 2 have increased lipid prevalence. An increase in cholesterol levels can reach 28% to 34%. High cholesterol levels accompanied by an increase in blood pressure in people with type-2 DM can increase the risk of cardiovascular disease. Proper nutritional support in the patient with type-2 DM is needed in controlling blood sugar along with controlling cholesterol levels and blood pressure. FortemDia_Tri is the development of a liquid dietary modification as nutritional support based on tempeh flour and mung beans as the main source of isoflavones and other ingredients such as skim milk flour, brown rice flour, canola oil, and maltodextrin, which are recommended for type-2 DM patients. Most commercial formulas do not contain isoflavones. The purpose of this research is to determine the effect of nutritional support for commercial formulas and FortemDia_Tri on reducing cholesterol levels and blood pressure in patients with type-2 DM. The sample of this study includes 33 patients with type-2 DM with the sample who neither takes insulin therapy nor consumes cholesterol-lowering drugs. Some samples were divided into 3 groups: control group (P1) given DM dietary education (n=11), P2 group given commercial formula (n = 11), and P3 group given the FortemDia_Tri (n=11). The dosage of commercial formula and FortemDia_Tri was 500 ml and 400 ml/day/person given 2 times/day, respectively. The intervention was done in 5 days. This study is analytical research with a randomized experimental study approach. The research design used is the pretest-posttest control-group design. The data of this research were analyzed with a one-way ANOVA test with the posthoc LSD test. After 5 days of treatment, there was a change in the level of total cholesterol of P2 group (-8.91 ± 23.17 mg/dl) with p = 0.231, and P3 group (-40.09 ± 25.04 mg/dl) with p = 0.000). Meanwhile, there was no change in the control group, and there was a significant difference between those groups (p = 0.001). P3 group has reduced more blood pressure than P1 and P2 groups, but the decrease was not different between the groups (p > 0.05). The FortemDia_Tri nutritional support can help reduce cholesterol levels and blood pressure in patients with type-2 DM. Further studies with longer duration and more sample sizes areneeded.","PeriodicalId":424952,"journal":{"name":"Proceedings of the International Conference on Health and Medical Sciences (AHMS 2020)","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133987005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.2991/AHSR.K.210127.009
Ismarwati, Mulyanto, Soetrisno, S. Mulyani
— Global Burden of Cancer identified that cervical cancer is the fourth most cancer, but is the second most cancer in women aged 15-44 years and is estimated to be> 80% in developing countries. This research is a qualitative research with casus study approach. Sampling was done by using purposive sampling technique. The use of video media containing cervical cancer material and early detection can increase knowledge and positive attitudes towards cervical cancer and early detection. Conclusion: The use of video in health promotion can increase knowledge and positive attitudes towards cervical cancer and early detection. Knowledge and positive attitude towards the urgency of early detection of cervical cancer are fully practiced in the form of concrete behavior.
{"title":"The Usage of Video in Encouraging Women With Cervical Cancer Risk to Do Early Detection: A Qualitative Study","authors":"Ismarwati, Mulyanto, Soetrisno, S. Mulyani","doi":"10.2991/AHSR.K.210127.009","DOIUrl":"https://doi.org/10.2991/AHSR.K.210127.009","url":null,"abstract":"— Global Burden of Cancer identified that cervical cancer is the fourth most cancer, but is the second most cancer in women aged 15-44 years and is estimated to be> 80% in developing countries. This research is a qualitative research with casus study approach. Sampling was done by using purposive sampling technique. The use of video media containing cervical cancer material and early detection can increase knowledge and positive attitudes towards cervical cancer and early detection. Conclusion: The use of video in health promotion can increase knowledge and positive attitudes towards cervical cancer and early detection. Knowledge and positive attitude towards the urgency of early detection of cervical cancer are fully practiced in the form of concrete behavior.","PeriodicalId":424952,"journal":{"name":"Proceedings of the International Conference on Health and Medical Sciences (AHMS 2020)","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117211367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.2991/AHSR.K.210127.024
Widya Mufida, Leny Latifah, J. Ardiyanto
This study aims to get the lowest mAs on CT Scan Facial Bone so that the radiation dose can be reduced. The reduction of radiation dose can reduce image quality, so digital image processing applications are used which aim to improve image quality so as to produce image information that is still acceptable. Keywords— mAs, slice thickness reconstruction, CT Scan
{"title":"Digital Image Processing in CT Scan Facial Bone With Low mAs to Improve Image Quality and Radiation Dose Reduction","authors":"Widya Mufida, Leny Latifah, J. Ardiyanto","doi":"10.2991/AHSR.K.210127.024","DOIUrl":"https://doi.org/10.2991/AHSR.K.210127.024","url":null,"abstract":"This study aims to get the lowest mAs on CT Scan Facial Bone so that the radiation dose can be reduced. The reduction of radiation dose can reduce image quality, so digital image processing applications are used which aim to improve image quality so as to produce image information that is still acceptable. Keywords— mAs, slice thickness reconstruction, CT Scan","PeriodicalId":424952,"journal":{"name":"Proceedings of the International Conference on Health and Medical Sciences (AHMS 2020)","volume":"125 s1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120843142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：